Description
(511 genes Mutation, Copy Number variations
and Fusion analysis with TMB, PD-L1, MSI)
Tissue, NA, Fasting or Non Fasting: As suggested by doctor
Sample Required:
FFPE tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C; tumour content >10%.
Test Time:
Biopsy-dependent. 8–12 working days.
Test Normal Range:
No fixed normal range.
What is the Test?
A multi-platform tumour analysis covering **511 genes**, including **mutations, CNVs, fusions, TMB, PD-L1**, and **microsatellite instability (MSI)**. Provides one of the most comprehensive molecular and immunophenotypic profiles for personalised oncology.
Test Procedure:
Tissue is processed for NGS (511 genes), IHC for PD-L1, and MSI assessment, integrating results into a unified diagnostic report.
When to Take the Test:
When detailed molecular and immune biomarker profiling is necessary to refine therapy selection.
Who Should Take This Test:
Patients with difficult, advanced or recurrent cancers where broad profiling can influence treatment strategy.
Precautions for Exceptional Cases (Pregnancy, etc.):
Discuss pregnancy or bleeding disorders before biopsy; ensure proper tissue fixation.